Page last updated: 2024-08-25

mitozolomide and Cancer of Prostate

mitozolomide has been researched along with Cancer of Prostate in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Domarkas, J; Fang, Y; Gao, X; Gibbs, BF; Jean-Claude, BJ; Larroque-Lombard, AL; Qiu, Q; Rachid, Z; Rao, S	1

Other Studies

1 other study(ies) available for mitozolomide and Cancer of Prostate

Article	Year
"Combi-targeting" mitozolomide: conferring novel signaling inhibitory properties to an abandoned DNA alkylating agent in the treatment of advanced prostate cancer. The Prostate, 2012, Sep-01, Volume: 72, Issue:12 Topics: Animals; Antineoplastic Agents, Alkylating; Cell Line, Tumor; DNA; Drug Delivery Systems; Humans; Male; Mice; NIH 3T3 Cells; Nitrogen Mustard Compounds; Prostatic Neoplasms; Signal Transduction; Treatment Outcome; Xenograft Model Antitumor Assays	2012

Article

Year

"Combi-targeting" mitozolomide: conferring novel signaling inhibitory properties to an abandoned DNA alkylating agent in the treatment of advanced prostate cancer.

The Prostate, 2012, Sep-01, Volume: 72, Issue:12

Topics: Animals; Antineoplastic Agents, Alkylating; Cell Line, Tumor; DNA; Drug Delivery Systems; Humans; Male; Mice; NIH 3T3 Cells; Nitrogen Mustard Compounds; Prostatic Neoplasms; Signal Transduction; Treatment Outcome; Xenograft Model Antitumor Assays

2012